These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10896995)

  • 21. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
    Haffty BG; Toth M; Flynn S; Fischer D; Carter D
    J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.
    Camplejohn RS; Ash CM; Gillett CE; Raikundalia B; Barnes DM; Gregory WM; Richards MA; Millis RR
    Br J Cancer; 1995 Jan; 71(1):140-5. PubMed ID: 7819030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
    Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
    De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
    Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
    Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA flow cytometry in surgically treated lung cancer--prognostic significance.
    Ikonen JT; Ojala A; Salenius JP; Mattila J; Riekkinen H; Wigren T
    Scand Cardiovasc J; 1999; 33(4):228-33. PubMed ID: 10517210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer.
    Abad M; Ciudad J; Rincon MR; Silva I; Paz-Bouza JI; Lopez A; Alonso AG; Bullon A; Orfao A
    Anal Cell Pathol; 1998; 16(4):223-31. PubMed ID: 9762369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
    Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD
    Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
    Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
    Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
    Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
    Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA flow cytometry in gastric carcinoma: implication in patients with potentially curative resection.
    Omejc M; Repse S; Bracko M
    J Surg Oncol; 1997 Aug; 65(4):237-41. PubMed ID: 9274787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.